Evidence map›Paper›PMID 33945003›Full record

ArticleJournal of neurology2021

Progressive apraxia of speech: delays to diagnosis and rates of alternative diagnoses.

Johnny Dang, Jonathan Graff-Radford, Joseph R Duffy, Rene L Utianski, Heather M Clark, Julie A Stierwalt, Jennifer L Whitwell, Keith A Josephs, Hugo Botha

Open access · greenAbstract read
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Automated Detection of Motor Speech Disorders and Subtype Classification.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Rate Modulation Abilities in Acquired Motor Speech Disorders.Journal of speech, language, and hearing research : JSLHR · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Johnny DangDepartment of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Joseph R DuffyDepartment Neurology Division of Speech Pathology, Mayo Clinic, Rochester, MN, USA.
Rene L UtianskiDepartment Neurology Division of Speech Pathology, Mayo Clinic, Rochester, MN, USA.
Heather M ClarkDepartment Neurology Division of Speech Pathology, Mayo Clinic, Rochester, MN, USA.
Julie A StierwaltDepartment Neurology Division of Speech Pathology, Mayo Clinic, Rochester, MN, USA.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Keith A JosephsDepartment of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Hugo BothaDepartment of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. Botha.Hugo@mayo.edu.ORCID http://orcid.org/0000-0003-4390-685X
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6M
The neurobiology of two distinct types of progressive apraxia of speechR01DC014942 · NIDCD · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Rene Lynn Utianski · 2017 to 2026
$4.9M
PIB PET Scanning in Speech and Language Based DementiasR01DC010367 · NIDCD · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2014
$1.7M
Foundation for the National Institutes of Health R01-DC010367Foundation for the National Institutes of Health R01-DC12519Foundation for the National Institutes of Health R01-DC14942Foundation for the National Institutes of Health R01-NS89757NIDCD NIH HHS R01 DC010367NIDCD NIH HHS R01 DC012519NIDCD NIH HHS R01 DC014942NINDS NIH HHS R01 NS089757
6 · The paper itself

Abstract

backgroundProgressive apraxia of speech (PAOS) is a neurodegenerative disorder of speech programming distinct from aphasia and dysarthria, most commonly associated with a 4-repeat tauopathy. Our objective was to better understand the reasons for possible delays or diagnostic errors for patients with PAOS.

methodsSeventy-seven consecutive PAOS research participants from the Neurodegenerative Research Group were included in this study. The medical records for these patients were reviewed in detail. For each speech-related visit, data such as the chief complaint, clinical findings, and neuroimaging findings were recorded.

resultsApraxia of speech was the initial diagnosis in 20.1% of participants at first evaluation noted in the historical record. Other common diagnoses included primary progressive aphasia (PPA) (20.1%), dysarthria (18.18%), MCI/Dementia (6.5%), and motor neuron disease (3.9%). It took a median of 2.02 (range: 0.16-8.18) years from symptoms onset for participants to receive an initial diagnosis and 3.00 (range: 0.49-9.42) years to receive a correct diagnosis. Those who were seen by a speech-language pathologist (SLP) during their first documented encounter were more likely to be correctly diagnosed with PAOS (37/48) after SLP consultation than those who were not seen by an SLP on initial encounter (5/29) (p < 0.001).

conclusionApproximately 80% of patients with PAOS were imprecisely diagnosed at their first visit, with it taking a median of 3 years from symptom onset to receiving a diagnosis of PAOS. Being seen by a speech-language pathologist during the initial evaluation increased the likelihood of a correct apraxia of speech diagnosis.

Indexed as

AphasiaAphasia, Primary ProgressiveApraxiasHumansNeuroimagingSpeechDiagnostic delayFrontotemporal dementiaPrimary progressive aphasiaProgressive apraxia of speech

Identifiers

PMID33945003
PMCPMC8566317
OpenAlexW3158679803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.